Thermo Fisher Scientific agrees to sell its microbiology business to private equity firm Astorg for over $1 billion.
Thermo Fisher Scientific has agreed to divest its microbiology business to Astorg, a private equity firm, for more than $1 billion. The deal represents a significant asset sale by Thermo Fisher as it continues to reshape its portfolio. No closing date has been publicly specified in the available reporting.
8
Divergence score
This event sits in the top 94% of divergence this week. 2 outlets covered it, splitting into 2 framing camps across 2 bias groups.
2 camps
2 bias groups
Market signalBETA
The spectrum · how 2 outlets placed this story
LeftCenterRight
Wall Street Journal
Reuters
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Both outlets report the same deal; Reute...
How each outlet covered it
Fact ledger · what actually happened, cross-checked